Comparing Idiopathic Chronic Fatigue and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Males: Response to Two-Day Cardiopulmonary Exercise Testing Protocol.
van Campen, C Linda M C, Visser, Frans C · Healthcare (Basel, Switzerland) · 2021 · DOI
Quick Summary
This study compared how men with ME/CFS respond to exercise testing on two consecutive days versus men with chronic fatigue that doesn't meet ME/CFS criteria. When ME/CFS patients exercised on the second day, they performed worse and couldn't reach the same levels they achieved on day one. Men with chronic fatigue (but not ME/CFS) actually improved on day two, similar to healthy people.
Why It Matters
This study provides objective physiological evidence that ME/CFS produces a characteristic abnormal response to exercise (post-exertional malaise) that distinguishes it from other forms of chronic fatigue. The two-day CPET protocol may serve as a useful biomarker to help clinicians differentiate between ME/CFS and other fatigue conditions, improving diagnostic accuracy and potentially guiding treatment decisions.
Observed Findings
ME/CFS patients showed significant decline in oxygen consumption and workload from CPET1 to CPET2
ICF patients showed improved performance on CPET2, similar to sedentary controls
Resting heart rate and respiratory exchange ratio did not differ significantly between the two testing days in either group
All other CPET parameters at ventilatory threshold and maximum exercise differed significantly between groups (p-values 0.002 to <0.0001)
Seven ME/CFS patients had fibromyalgia compared to zero ICF patients
Inferred Conclusions
Male ME/CFS patients demonstrate exercise intolerance characterized by deteriorating performance on a second consecutive day of testing
This two-day CPET response pattern appears specific to ME/CFS and may help distinguish it from other forms of chronic fatigue
The abnormal response to repeated exercise in ME/CFS aligns with published findings in male ME/CFS populations and supports the biological distinctiveness of the condition
Remaining Questions
Does this two-day CPET response pattern differ in female ME/CFS patients, who comprise the majority of the patient population?
What physiological mechanisms underlie the deterioration in exercise performance observed on day 2 in ME/CFS patients?
What This Study Does Not Prove
This study does not prove that the two-day CPET can be used routinely in clinical practice—it was conducted in a research setting with relatively small numbers. It does not establish why ME/CFS patients show this deterioration pattern, only that they do. Results are limited to males and may not apply to female ME/CFS patients, who represent the majority of the ME/CFS population.